Immunosuppressive parameters in serum of ovarian cancer patients change during the disease course
出版年份 2015 全文链接
标题
Immunosuppressive parameters in serum of ovarian cancer patients change during the disease course
作者
关键词
-
出版物
OncoImmunology
Volume 5, Issue 4, Pages e1111505
出版商
Informa UK Limited
发表日期
2015-12-21
DOI
10.1080/2162402x.2015.1111505
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- FIGO 2013 staging system for ovarian cancer
- (2015) Shivani R. Kandukuri et al. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- Plasma immune analytes in patients with epithelial ovarian cancer
- (2015) Matthew S. Block et al. CYTOKINE
- Immunosuppression through constitutively activated NF-κB signalling in human ovarian cancer and its reversal by an NF-κB inhibitor
- (2014) H Nishio et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
- (2014) Rakesh K. Jain CANCER CELL
- Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors
- (2014) Diego O. Croci et al. CELL
- Tumor-Associated Macrophages: From Mechanisms to Therapy
- (2014) Roy Noy et al. IMMUNITY
- Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
- (2014) Oscar R. Colegio et al. NATURE
- Role of IL-17F T7488C polymorphism in carcinogenesis: a meta-analysis
- (2014) Fen Yao et al. TUMOR BIOLOGY
- Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer
- (2014) P Zhang et al. Cell Death & Disease
- Chronic Inflammation and Cytokines in the Tumor Microenvironment
- (2014) Glauben Landskron et al. Journal of Immunology Research
- Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity
- (2013) Andrea Casazza et al. CANCER CELL
- High density of IL-17-producing cells is associated with improved prognosis for advanced epithelial ovarian cancer
- (2013) Chunyan Lan et al. CELL AND TISSUE RESEARCH
- Tu-be or not tu-be: That is the question… About serous ovarian carcinogenesis
- (2013) G. Chene et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Altered galectin-1 serum levels in patients diagnosed with high-grade glioma
- (2013) Tina Verschuere et al. JOURNAL OF NEURO-ONCOLOGY
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- Clinical significance of serum epithelial cell adhesion molecule (EPCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in patients with epithelial ovarian cancer
- (2013) Faruk Tas et al. TUMOR BIOLOGY
- A role for CCL2 in both tumor progression and immunosurveillance
- (2013) Ming Li et al. OncoImmunology
- Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment
- (2012) Koichi Ito et al. CANCER AND METASTASIS REVIEWS
- Galectin-1 Promotes Lung Cancer Progression and Chemoresistance by Upregulating p38 MAPK, ERK, and Cyclooxygenase-2
- (2012) L.-Y. Chung et al. CLINICAL CANCER RESEARCH
- High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion
- (2012) Ha-Jeong Kim et al. EUROPEAN JOURNAL OF CANCER
- The prognostic value of vascular endothelial growth factor in ovarian cancer: A systematic review and meta-analysis
- (2012) Lei Yu et al. GYNECOLOGIC ONCOLOGY
- Dual Roles of Immune Cells and Their Factors in Cancer Development and Progression
- (2012) Brian F. Zamarron et al. International Journal of Biological Sciences
- Alternative activation of tumor-associated macrophages by IL-4
- (2011) Hao-Wei Wang et al. CELL CYCLE
- IL-13 regulates cancer invasion and metastasis through IL-13Rα2 via ERK/AP-1 pathway in mouse model of human ovarian cancer
- (2011) Toshio Fujisawa et al. INTERNATIONAL JOURNAL OF CANCER
- Expression of TGFß1 and its receptors is associated with biological features of ovarian cancer and sensitivity to paclitaxel/carboplatin
- (2011) Komiyama ONCOLOGY REPORTS
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients
- (2010) Sven Mahner et al. BMC CANCER
- Myeloid-Derived Suppressor Cells in Human Cancer
- (2010) Srinivas Nagaraj et al. CANCER JOURNAL
- Ovarian cancer creates a suppressive microenvironment to escape immune elimination
- (2010) Refika Yigit et al. GYNECOLOGIC ONCOLOGY
- Chemotherapy Induces Macrophage Chemoattractant Protein-1 Production in Ovarian Cancer
- (2010) Melissa A. Geller et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
- (2010) Ignace Vergote et al. NEW ENGLAND JOURNAL OF MEDICINE
- p53 autoantibodies, cytokine levels and ovarian carcinogenesis
- (2009) Miyun Tsai-Turton et al. GYNECOLOGIC ONCOLOGY
- Ovarian cancer cytoreduction induces changes in T cell population subsets reducing immunosuppression
- (2009) Chiara Napoletano et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
- (2009) Satish L. Deshmane et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Evidence of galectin-1 involvement in glioma chemoresistance☆
- (2008) Marie Le Mercier et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search